Adaptvac

mRNA
#Adaptvac #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #University of Copenhagen

Virus-like particles enhance effect of mRNA vaccines

Researchers from Denmark have demonstrated that a simple addition to mRNA vaccines can significantly enhance their effectiveness.  mRNA technology is highly effective against viruses and quick to adapt to new variants, but the immunity tends to wane rapidly, leaving people vulnerable to reinfection just months after vaccination. Read More

#Editor's Choice #News

#Adaptvac #CEPI #Disease X #Ebola virus #Immunology / Virology & Vaccines #Pandemic prevention

All-in-one vaccine development backed by $12.4m funding

Scientists at Denmark’s Adaptvac will lead the development of a new vaccine that could provide all-in-one protection against multiple deadly viruses, including Ebolavirus Zaire, Sudan Ebolavirus and Marburg.  Backed by $12.4 million of funding from CEPI and the European Union’s Horizon Europe programme, a global consortium led… Read More

#Editor's Choice #News